Header Logo

Connection

James Mulshine to Indium Radioisotopes

This is a "connection" page, showing publications James Mulshine has written about Indium Radioisotopes.
Connection Strength

0.277
  1. Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Clin Cancer Res. 1999 Nov; 5(11):3385-93.
    View in: PubMed
    Score: 0.170
  2. Direct intralymphatic injection of radiolabeled 111In-T101 in patients with cutaneous T-cell lymphoma. Cancer Res. 1991 Jan 15; 51(2):688-95.
    View in: PubMed
    Score: 0.093
  3. Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma. Clin Cancer Res. 1998 Nov; 4(11):2691-700.
    View in: PubMed
    Score: 0.010
  4. The pharmacology of monoclonal antibodies. Ann N Y Acad Sci. 1987; 507:199-210.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.